Medical AI Alliance
← Company Index
Medical DevicesKOSDAQ 30255067 approvals

REMED CO.,LTD.

Official website

KOSDAQ-listed magnetic stimulation medical device company developing TMS-based brain rehabilitation devices and PMS pain management devices.

As of 2026-10-10, REMED CO.,LTD. has 64 Korean MFDS device approvals, 3 US FDA clearances/approvals, 5 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2003 and listed on KOSDAQ in 2019, REMED is a medical device company specializing in magnetic stimulation therapy devices. It operates a brain rehabilitation business using transcranial magnetic stimulation (TMS), a chronic pain treatment business using its Pain Management Solution (PMS), a muscle-strengthening business using Core Muscle Strengthening Magnetic Stimulation (CSMS), and an aesthetic business using Energy Based Devices (EBD). Its TMS device completed confirmatory clinical trials for depression treatment, launched in Korea, China, Japan, and Europe, and received U.S. FDA clearance, and is now in confirmatory trials for improving memory and cognitive function in Alzheimer's disease, while its PMS device launched for pain treatment in Korea, China, and Europe and also received U.S. FDA clearance.

Products & technology

  • TMS brain rehabilitation deviceTranscranial magnetic stimulation device for depression, Alzheimer's disease, and drug-resistant epilepsy treatment/rehabilitation
  • PMS pain management solutionChronic pain treatment device for musculoskeletal pain and herniated disc
  • CSMS muscle-strengthening magnetic stimulation deviceMuscle strengthening via magnetic stimulation
  • EBD aesthetic deviceElectrical, light, and ultrasound energy-based aesthetic device

Regulatory approvals

data.go.kr · openFDA

64 Korean MFDS device approvals · 2004–2026 / 3 US FDA 510(k) · 2021–2022

  • MFDSCombination stimulator, class 32026-04-02
    Product approval · Class 3제허 26-255 호
  • MFDSLaser, therapeutic2025-12-15
    Product approval · Class 3제허 25-839 호
  • MFDSElectrode, external2025-10-29
    Product approval · Class 1제신 25-1431 호
  • MFDSExtracorporeal shock wave treatment system2025-10-14
    Product approval · Class 3제허 25-688 호
  • MFDSElectrode, electric stimulator, external2025-09-30
    Product approval · Class 1제신 25-1302 호
  • MFDSElectromagnetic therapy stimulator2025-05-13
    Product approval · Class 2제인 25-4404 호
  • MFDSStereotaxic unit, navigation2024-12-05
    Product approval · Class 2제인 24-1111 호
  • MFDSElectromyograph2024-06-28
    Product approval · Class 2제인 24-640 호
  • MFDSElectromagnetic therapy stimulator2024-03-27
    Product approval · Class 2제인 24-339 호
  • MFDSElectromagnetic therapy stimulator2023-12-15
    Product approval · Class 2제인 23-5362 호
  • MFDSElectromagnetic therapy stimulator2023-06-16
    Product approval · Class 2제인 23-4807 호
  • FDAALTMS Magnetic Stimulation Therapy System, Blossom TMS Therapy System2022-04-06
    510(k) · SpecialNeurologyK220625
Show 55 more
  • FDAALTMS Magnetic Stimulation Therapy System2021-11-26
    510(k) · TraditionalNeurologyK202537
  • MFDSTranscutaneous electrical modulation system, scrambling2021-08-04
    Product approval · Class 2제인 21-4668 호
  • MFDSExtracorporeal shock wave treatment system2021-07-02
    Product approval · Class 3제허 21-555 호
  • MFDSElectromagnetic therapy stimulator2021-06-29
    Product approval · Class 2제인 21-4561 호
  • MFDSExtracorporeal shock wave treatment system2021-06-21
    Product approval · Class 3제허 21-493 호
  • MFDSElectromagnetic therapy stimulator2021-06-08
    Product approval · Class 2제인 21-4495 호
  • MFDSDiathermy treatment system operator console, high frequency2021-05-27
    Product approval · Class 3제허 21-425 호
  • MFDSElectromagnetic therapy stimulator2021-05-20
    Product approval · Class 2제인 21-4425 호
  • MFDSElectromagnetic therapy stimulator2021-05-20
    Product approval · Class 2제인 21-4424 호
  • FDATalent-Pro Electromagnetic Stimulator2021-05-06
    510(k) · TraditionalPhysical MedicineK202031
  • MFDSLaser, therapeutic2020-06-08
    Product approval · Class 3제허 20-454 호
  • MFDSElectromagnetic therapy stimulator2020-04-08
    Product approval · Class 2제인 20-4269 호
  • MFDSExtracorporeal shock wave treatment system2019-01-25
    Product approval · Class 3제허 19-72 호
  • MFDSExtracorporeal shock wave treatment system2018-12-12
    Product approval · Class 3제허 18-798 호
  • MFDSExtracorporeal shock wave treatment system2018-08-22
    Product approval · Class 3제허 18-581 호
  • MFDSElectrosurgical system, general-purpose2017-09-14
    Product approval · Class 3제허 17-701 호
  • MFDSLaser, therapeutic2017-02-23
    Product approval · Class 3제허 17-141 호
  • MFDSElectromagnetic therapy stimulator2016-05-12
    Product approval · Class 2제인 16-4391 호
  • MFDSElectromagnetic therapy stimulator2016-02-23
    Product approval · Class 2제인 16-4157 호
  • MFDSExtracorporeal shock wave treatment system2015-08-07
    Product approval · Class 3제허 15-1285 호
  • MFDSElectrosurgical system, general-purpose2015-06-04
    Product approval · Class 3제허 15-885 호
  • MFDSElectrosurgical system, general-purpose2015-05-28
    Product approval · Class 3제허 15-807 호
  • MFDSSystem, isokinetic testing and evaluationRevoked2015-05-06
    Product approval · Class 2제허 15-683 호
  • MFDSElectromagnetic therapy stimulator2014-08-20
    Product approval · Class 2제인 14-1513 호
  • MFDSExtracorporeal shock wave treatment system2014-08-19
    Product approval · Class 3제허 14-1505 호
  • MFDSExtracorporeal shock wave treatment system2014-08-19
    Product approval · Class 3제허 14-1506 호
  • MFDSLaser, therapeutic2014-03-11
    Product approval · Class 3제허 14-591 호
  • MFDSStimulator, evoked response2013-10-11
    Product approval · Class 2제인 13-1721 호
  • MFDSElectrosurgical system, general-purpose2013-07-29
    Product approval · Class 3제허 13-1349 호
  • MFDSElectrosurgical system, general-purpose2013-07-29
    Product approval · Class 3제허 13-1350 호
  • MFDSElectromagnetic therapy stimulator2013-05-09
    Product approval · Class 2제허 13-820 호
  • MFDSLaser, therapeutic2011-11-25
    Product approval · Class 3제허 11-1290 호
  • MFDSLow frequency electric stimulator for medical use, home useRevoked2011-05-25
    Product approval · Class 2제허 11-574 호
  • MFDSExtracorporeal shock wave treatment system2010-07-13
    Product approval · Class 3제허 10-681 호
  • MFDSLaser, therapeuticRevoked2010-05-25
    Product approval · Class 3제허 10-523 호
  • MFDSElectroencephalograph2010-03-25
    Product approval · Class 2제인 10-261 호
  • MFDSExtracorporeal shock wave treatment systemRevoked2009-04-10
    Product approval · Class 3제허 09-246 호
  • MFDSLaser, therapeutic2008-04-16
    Product approval · Class 3제허 08-208 호
  • MFDSLaser, therapeutic2008-03-14
    Product approval · Class 3제허 08-141 호
  • MFDS레이저수술기Revoked2007-07-09
    Product approval · Class 3제허 07-380 호
  • MFDS개인용초음파자극기Revoked2007-06-21
    Product approval · Class 2제허 07-332 호
  • MFDS피부저항측정기Revoked2007-02-09
    Product approval · Class 2제허 07-68 호
  • MFDS초음파자극기Revoked2006-11-06
    Product approval · Class 3제허 06-831 호
  • MFDS의료용조합자극기Revoked2006-09-14
    Product approval · Class 3제허 06-688 호
  • MFDS의료용조합자극기Revoked2006-09-14
    Product approval · Class 3제허 06-684 호
  • MFDS초음파자극기Revoked2006-08-03
    Product approval · Class 3제허 06-558 호
  • MFDS저주파자극기Revoked2006-07-11
    Product approval · Class 2제허 06-489 호
  • MFDS의료용레이저조사기Revoked2006-04-07
    Product approval · Class 3제허 06-261 호
  • MFDS개인용저주파자극기Revoked2006-03-24
    Product approval · Class 2제허 06-211 호
  • MFDS개인용전위발생기Revoked2006-03-24
    Product approval · Class 2제허 06-212 호
  • MFDS의료용레이저조사기Revoked2006-02-22
    Product approval · Class 3제허 06-142 호
  • MFDS의료용적외선촬영장치Revoked2005-05-30
    Product approval · Class 2제허 05-456 호
  • MFDSStimulator, evoked response2005-02-02
    Product approval · Class 2제인 05-96 호
  • MFDS온욕요법용장치Revoked2004-09-20
    Product approval · Class 1경인 제신 04-125 호
  • MFDS의료용레이저조사기Revoked2004-08-20
    Product approval · Class 3제허 04-863 호

R&D and key agreements

Source: DART corporate disclosure

TMS 알츠하이머병 기억력·인지기능 개선 · 알츠하이머병 · 탐색임상 완료, 확증임상 진행중 · Evaluating memory and cognitive function improvement via TMS in Alzheimer's patients under drug treatment

TMS 약물난치성뇌전증 치료 · 약물난치성뇌전증 · 탐색임상 완료

PMS 근골격계 통증 치료 · 근골격계 통증 · 탐색임상 완료

PMS 디스크 탈출증 치료 · 디스크 탈출증 · 탐색임상 완료

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 68 more patents

AI reads

MAA server logs · IP-verified
116
Times AI engines pulled REMED CO.,LTD.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

4
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

112
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

13
live 1
Last 7 days
83
live 3
Last 30 days
116
live 4
All time
  • OpenAIChatGPT-Userlive4
  • OpenAIOAI-SearchBot94
  • GoogleGoogleOther11
  • PerplexityPerplexityBot5
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for REMED CO.,LTD. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

CLASSYS Inc.7 shared

CLASSYS Inc., established in 2015 and listed on KOSDAQ, makes aesthetic medical devices using HIFU, MRF, MNRF, and laser technologies.

Dynamic solution Co.,Ltd.6 shared

Founded in 2010 and KOSDAQ-listed in 2018, Dynamic Solution makes AI/IoT-based rehabilitation devices like the Rapael Smart Glove.

WON TECH CO.,Ltd.5 shared

Founded in 2019 and KOSDAQ-listed the same year, WON TECH makes aesthetic laser, RF, and HIFU devices including Oligio and Picocare.

WonIk Co.,LTD3 shared

WonIk, founded in 1983 and KOSDAQ-listed in 1997, operates pressure sensor, dermo-cosmetic, and medical device distribution businesses.

BTB Korea Co.,Ltd3 shared

KOSDAQ-listed aesthetic medical device company producing PICO, DUAL HI, and other anti-aging and body-contouring devices.

Hironic Co.,Ltd3 shared

KOSDAQ-listed medical device company producing HIFU devices DOUBLO/V-RO and the Synerjet non-invasive drug delivery system for aesthetic dermatology.

ASTERASYS Co., Ltd.2 shared

Founded in 2015 and listed on KOSDAQ in 2025, ASTERASYS manufactures HIFU and RF-based aesthetic skin devices.

OSANG HEALTHCARE CO.,LTD.2 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

CU MEDICAL SYSTEMS Inc.2 shared

Founded in 2001 and KOSDAQ-listed in 2011, CU Medical Systems makes AEDs and other emergency medical devices.

BIODYNE CO., LTD.2 shared

Founded in 1999 and KOSDAQ-listed in 2021, BIODYNE develops liquid-based cytology (LBC) devices and diagnostic reagent kits.

Alpha AI Co.,Ltd.2 shared

Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.

BIO PROTECH INC.2 shared

Manufactures biosensors for electronic medical device consumables, including ECG measurement electrodes.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition